Related Experiment Video
Updated: Jul 12, 2025

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
Nivolumab-Induced Isolated Neutropenia
Aimal Waqas1, Javariya Zaffar2, Ahmad Jalil3
1Internal Medicine, Foundation University Medical College, Islamabad, PAK.
Immune checkpoint inhibitors (ICIs) can cause rare but severe neutropenia. This case highlights the importance of monitoring for hematologic adverse effects, even in asymptomatic patients, during ICI therapy for cancer.
Area of Science:
- Oncology
- Immunology
- Hematology
Background:
- Immune checkpoint inhibitors (ICIs) are revolutionary cancer therapies.
- ICIs can induce immune-related adverse events (irAEs) affecting various organ systems.
- Hematologic irAEs are rare but potentially severe complications of ICI treatment.
Observation:
- This report details a rare case of Grade 4 neutropenia.
- The neutropenia was a result of nivolumab (anti-PD-1 antibody) therapy.
- The patient had invasive bladder cancer.
Findings:
- Isolated neutropenia is a grave and rare manifestation of ICI-induced autoimmunity.
- Asymptomatic neutropenia requires vigilant monitoring.
- Severe neutropenia with fever necessitates immediate hospitalization and treatment.
Implications:
- Prompt recognition and management of ICI-induced neutropenia are crucial.
- Steroids and supportive care can effectively treat nivolumab-induced neutropenia.
- This case underscores the need for awareness of hematologic toxicities in patients receiving ICIs.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

